{"id":"controlled-substances-controlled-drugs-precursors-and-plants-regulations-2014","name":"Controlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2014","slug":"controlled-substances-controlled-drugs-precursors-and-plants-regulations-2014","collection":"regulation","jurisdiction":"sa","status":"in_force","isInForce":true,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":235317,"registerId":"sa-controlled-substances-controlled-drugs-precursors-and-plants-regulations-2014-current","compilationNumber":null,"startDate":"2026-04-06","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Controlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2014","content":"South Australia\nControlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2014\nunder the Controlled Substances Act 1984\n\nContents\n1\tShort title\n3\tInterpretation\n4\tElectronic drug detection\n5\tDeclaration of controlled drugs, controlled precursors and controlled plants\n6\tPrescribed quantities of controlled drugs, controlled precursors and controlled plants\n6A\tExemptions—section 33I(2)\n7\tPrescribed number of cannabis plants (section 33K)\n8\tExemption from prohibition of possession of injecting equipment\n8A\tExemption—section 33L(2)\n9\tPrescribed equipment (section 33LA)\n10\tPrescribed quantity of mixture containing controlled precursors (section 33LB)\n11\tPrescribed equipment (sections 33LB and 33J)\n12\tNo accessorial liability in prescribed circumstances\n13\tPrescribed place\n14\tExpiation fees for simple cannabis offences\n15\tSimple cannabis offences\n16\tTaking of cannabis samples (section 52E(6))\n17\tPrescribed manner of initiation of analysis and prescribed fee\n18\tPrescribed form of certificate of analysis (section 53(4))\nSchedule 1—Controlled drugs\nPart 1—Controlled drugs other than drugs of dependence\nPart 2—Drugs of dependence\nSchedule 2—Controlled precursors\nSchedule 3—Controlled plants\nPart 1—Controlled plants other than cannabis plants\nPart 2—Cannabis plants\nSchedule 4—Certificate of analysis\nSchedule 5—Expiation fees\nSchedule 6—Transitional provisions\n2\tTransitional provisions\nLegislative history\n\n1—Short title\nThese regulations may be cited as the Controlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2014.\n3—Interpretation\nIn these regulations, unless the contrary intention appears—\nAct means the Controlled Substances Act 1984;\ncertified hemp seed has the same meaning as in the Industrial Hemp Act 2017;\nDDU means discrete dosage unit;\nhemp seed oil means the oil obtained by cold expression from the seeds of cannabis;\nindustrial hemp has the same meaning as in the Industrial Hemp Act 2017;\nlow THC cannabis means cannabis sativa the leaves and flowering heads of which contain not more than 1% of tetrahydrocannabinol;\nlow THC cannabis food product means any of the following products in which there is not more than 75 mg/kg of cannabidiol present:\n\t(a)\tcannabis seeds if—\n\t(i)\tthe seeds are of low THC cannabis; and\n\t(ii)\tthe seeds contain not more than 5 mg/kg of total tetrahydrocannabinols; and\n\t(iii)\tthe only cannabinoids in or on the seeds are naturally present; and\n\t(iv)\tif the seeds are a food for retail sale or used as an ingredient in a food for retail sale—the seeds are non-viable and hulled;\n\t(b)\themp seed oil that is extracted from seeds of low THC cannabis if the oil contains not more than 10 mg/kg of total tetrahydrocannabinols and the only cannabinoids in the oil are those that were naturally present in or on the seeds from which the oil was extracted;\n\t(c)\ta beverage that is derived from seeds of low THC cannabis if the beverage contains not more than 0.2 mg/kg of total tetrahydrocannabinols and the only cannabinoids in the beverage are those that were naturally present in or on the seeds from which the beverage was derived;\n\t(d)\tany other product that is extracted or derived from seeds of low THC cannabis if the product contains not more than 5 mg/kg of total tetrahydrocannabinols and the only cannabinoids in the product are those that were naturally present in or on the seeds from which the product was extracted or derived;\nprescribed industrial hemp authority means—\n\t(a)\tthe holder of a licence under the Industrial Hemp Act 2017; or\n\t(b)\tan inspector authorised under the Industrial Hemp Act 2017; or\n\t(c)\ta supplier of certified hemp seeds; or\n\t(d)\ta supplier of industrial hemp; or\n\t(e)\ta person employed at a laboratory or place approved for examination and testing under section 19(1)(e) of the Industrial Hemp Act 2017;\nseed includes part of a seed;\nUniform Poisons Standard means the current Poisons Standard as defined in the Commonwealth Act (as in force from time to time).\n4—Electronic drug detection\n\t(1)\tFor the purposes of paragraph (b) of the definition of general drug detection in section 4(1) of the Act, an electronic drug detection system may only be used in the manner prescribed by this regulation.\n\t(2)\tAn electronic drug detection system may only be used in relation to a person in accordance with the following:\n\t(a)\tsamples of particulate matter may be taken from—\n\t(i)\tthe outside of the person's clothing; and\n\t(ii)\tthe person's hands,\nfor the purpose of analysis to detect the presence of a controlled drug, controlled precursor or controlled plant;\n\t(b)\tthe person cannot be required to remove, undo or rearrange any clothing for the purpose of taking such samples from the person's clothing; \n\t(c)\tin taking such samples from the person's clothing, care must be taken to avoid disturbing the person's clothing.\n\t(3)\tAn electronic drug detection system may only be used in relation to property (other than a vehicle) by taking samples of particulate matter from the outside of the property for the purpose of analysis to detect the presence of a controlled drug, controlled precursor or controlled plant.\n\t(4)\tAn electronic drug detection system may only be used in relation to a vehicle in accordance with the following:\n\t(a)\tsamples of particulate matter may be taken from both the exterior and interior of the vehicle (but not from the inside of any internal storage compartment) for the purpose of analysis to detect the presence of a controlled drug, controlled precursor or controlled plant;\n\t(b)\tarticles must not be removed from the vehicle for the purpose of taking such samples.\n\t(5)\tFor the purposes of this regulation, samples of particulate matter may be taken by swabbing, wiping or otherwise touching a surface to obtain a sample of particles from that surface.\n\t(6)\tIn this regulation—\ninternal storage compartment, in relation to a vehicle, means a glove box, drawer, cupboard, pocket or other similar compartment within the vehicle that is designed by the manufacturer—\n\t(a)\tfor the storage of items in the vehicle; and\n\t(b)\tto be capable of being sealed or closed,\nbut does not include general internal space within a vehicle such as the rear of a station wagon, panel van or van, the boot of a car or any other similar space;\nvehicle includes a caravan, trailer or anything else being towed by the vehicle.\n5—Declaration of controlled drugs, controlled precursors and controlled plants\n\t(1)\tIn accordance with section 12(4) of the Act, the following substances are declared to be controlled drugs:\n\t(a)\tthe natural or synthetic form of a substance listed in Schedule 1;\n\t(b)\tany salt, derivative or isomer of the natural or synthetic form of a substance listed in Schedule 1 and any salt of such derivative or isomer;\n\t(c)\tany analogue of the natural or synthetic form of a substance listed in Schedule 1 and any salt of such an analogue;\n\t(d)\tany homologue of the natural or synthetic form of a substance listed in Schedule 1 (being a homologue differing from the substance by 1 or more carbon containing groups (including methylene groups) in the chemical structure) and any salt of such a homologue;\n\t(e)\tany of the substances referred to in a preceding paragraph whether existing alone or in a preparation, admixture, solution or natural substance.\n\t(2)\tIn accordance with section 12(4a) of the Act, the following substances are declared to be controlled precursors:\n\t(a)\tthe natural or synthetic form of a substance listed in Schedule 2;\n\t(b)\tany salt, isomer, ester, ether, ketal, acetal, acetate, hydroxide, oxime, amide, imine, acid chloride, nitrile, anhydride, halogen substituent, epoxide, diol or any analogue or derivative of the natural or synthetic form of a substance listed in Schedule 2;\n\t(c)\tany of the substances referred to in a preceding paragraph whether existing alone or in a preparation, admixture, solution or natural substance.\n\t(3)\tIn accordance with section 12(4b) of the Act, the following plants are declared to be controlled plants:\n\t(a)\ta growing plant listed in Part 1 of Schedule 3;\n\t(b)\ta cutting taken from a plant listed in Part 1 of Schedule 3 (provided that the cutting has been planted or otherwise placed in a growing medium).\n6—Prescribed quantities of controlled drugs, controlled precursors and controlled plants\n\t(1)\tFor the purposes of the definition of large commercial quantity in section 4(1) of the Act, the quantity of a particular controlled drug or controlled plant prescribed as a large commercial quantity of the drug in its pure form or of the plant is—\n\t(a)\tin the case of a controlled drug—the amount (if any) listed in the subcolumn headed \"(pure)\" within the column headed \"Large commercial\" in the tables in Part 1 or Part 2 of Schedule 1 opposite the entry listing the controlled drug; or\n\t(b)\tin the case of a controlled plant—the amount (if any) listed in the column headed \"Large commercial\" in the tables in Part 1 or Part 2 of Schedule 3 opposite the entry listing the controlled plant.\n\t(2)\tFor the purposes of the definition of large commercial quantity in section 4(1) of the Act, the quantity of a mixture containing a particular controlled drug or controlled precursor prescribed as a large commercial quantity for any mixture containing the drug or precursor is—\n\t(a)\tin the case of a controlled drug—the amount (if any) listed in the subcolumn headed \"(mixed)\" within the column headed \"Large commercial\" in the tables in Part 1 or Part 2 of Schedule 1 opposite the entry listing the controlled drug; or\n\t(b)\tin the case of a controlled precursor—the amount (if any) listed in the column headed \"Large commercial (mixed)\" in the table in Schedule 2 opposite the entry listing the controlled precursor.\n\t(3)\tFor the purposes of the definition of large commercial quantity in section 4(1) of the Act, the number of DDUs of a mixture containing a particular controlled drug prescribed as a large commercial quantity for any mixture containing the controlled drug is the number of DDUs (if any) listed in the subcolumn headed \"(mixed)\" within the column headed \"Large commercial\" in the tables in Part 1 or Part 2 of Schedule 1 opposite the entry listing the controlled drug.\n\t(4)\tFor the purposes of the definition of commercial quantity in section 4(1) of the Act, the quantity of a particular controlled drug or controlled plant prescribed as a commercial quantity of the drug in its pure form or the plant is—\n\t(a)\tin the case of a controlled drug—the amount (if any) listed in the subcolumn headed \"(pure)\" within the column headed \"Commercial\" in the tables in Part 1 or Part 2 of Schedule 1 opposite the entry listing the controlled drug; or\n\t(b)\tin the case of a controlled plant—the amount (if any) listed in the column headed \"Commercial\" in the tables in Part 1 or Part 2 of Schedule 3 opposite the entry listing the controlled plant.\n\t(5)\tFor the purposes of the definition of commercial quantity in section 4(1) of the Act, the quantity of a mixture containing a particular controlled drug or controlled precursor prescribed as a commercial quantity for any mixture containing the drug or precursor is—\n\t(a)\tin the case of a controlled drug—the amount (if any) listed in the subcolumn headed \"(mixed)\" within the column headed \"Commercial\" in the tables in Part 1 or Part 2 of Schedule 1 opposite the entry listing the controlled drug; or\n\t(b)\tin the case of a controlled precursor—the amount (if any) listed in the column headed \"Commercial (mixed)\" in the table in Schedule 2 opposite the entry listing the controlled precursor.\n\t(6)\tFor the purposes of the definition of commercial quantity in section 4(1) of the Act, the number of DDUs of a mixture containing a particular controlled drug prescribed as a commercial quantity for any mixture containing the controlled drug is the number of DDUs (if any) listed in the subcolumn headed \"(mixed)\" within the column headed \"Commercial\" in the tables in Part 1 or Part 2 of Schedule 1 opposite the entry listing the controlled drug.\n\t(7)\tFor the purposes of the definition of trafficable quantity in section 4(1) of the Act, the quantity of a particular controlled drug (being a drug specified in Part 1 of Schedule 1) or controlled plant prescribed as a trafficable quantity of the drug in its pure form or of the plant is—\n\t(a)\tin the case of a controlled drug specified in Part 1 of Schedule 1—the amount (if any) listed in the subcolumn headed \"(pure)\" within the column headed \"Trafficable\" in the table in Part 1 of Schedule 1 opposite the entry listing the controlled drug; or\n\t(b)\tin the case of a controlled plant—the amount (if any) listed in the column headed \"Trafficable\" of the tables in Part 1 or Part 2 of Schedule 3 opposite the entry listing the controlled plant.\n\t(8)\tFor the purposes of the definition of trafficable quantity in section 4(1) of the Act, the quantity of a mixture containing a particular controlled drug prescribed as a trafficable quantity for any mixture containing the controlled drug is the amount (if any) listed in the subcolumn headed \"(mixed)\" within the column headed \"Trafficable\" in the tables in Part 1 or Part 2 of Schedule 1 opposite the entry listing the controlled drug.\n\t(9)\tFor the purposes of the definition of trafficable quantity in section 4(1) of the Act, the number of DDUs of a mixture containing a particular controlled drug prescribed as a trafficable quantity for any mixture containing the controlled drug is the number of DDUs (if any) listed in the subcolumn headed \"(mixed)\" within the column headed \"Trafficable\" in the tables in Part 1 or Part 2 of Schedule 1 opposite the entry listing the controlled drug.\n6A—Exemptions—section 33I(2)\n\t(1)\tA person is exempt from the application of section 33I(2) of the Act in respect of—\n\t(a)\tthe possession, supply or administration of a low THC cannabis food product; or\n\t(b)\tthe possession or supply of processed hemp fibre containing 0.1% or less of tetrahydrocannabinols (including hemp fibre products manufactured from such fibre); or\n\t(c)\tthe possession or supply of hemp seed oil containing cannabinoids at a level not exceeding 50 mg/kg for purposes other than internal human use; or\n\t(d)\tthe possession or supply of industrial hemp in the course of the person's employment at a laboratory or place approved for examination and testing under section 19(1)(e) of the Industrial Hemp Act 2017.\n\t(2)\tA person employed or engaged by a prescribed industrial hemp authority to transport industrial hemp to another industrial hemp authority is exempt from the application of section 33I(2) of the Act in respect of the possession and supply of industrial hemp for the purpose of such transport.\n7—Prescribed number of cannabis plants (section 33K)\nFor the purposes of section 33K of the Act, the prescribed number of cannabis plants is 5.\n8—Exemption from prohibition of possession of injecting equipment\nSection 33L(1)(c) of the Act does not apply to a person having in his or her possession a syringe or needle for use in connection with the administration of a controlled drug.\n8A—Exemption—section 33L(2)\n\t(1)\tA person is exempt from the application of section 33L(2) of the Act in respect of—\n\t(a)\tthe possession or consumption of a low THC cannabis food product; or\n\t(b)\tthe possession of processed hemp fibre containing 0.1% or less of tetrahydrocannabinols (including hemp fibre products manufactured from such fibre); or\n\t(c)\tthe possession of hemp seed oil containing cannabinoids at a level not exceeding 50 mg/kg for purposes other than internal human use; or\n\t(d)\tthe possession of industrial hemp in the course of the person's employment at a laboratory or place approved for examination and testing under section 19(1)(e) of the Industrial Hemp Act 2017.\n\t(2)\tA person employed or engaged by a prescribed industrial hemp authority to transport industrial hemp to another industrial hemp authority is exempt from the application of section 33L(2) of the Act in respect of the possession of industrial hemp for the purpose of such transport.\n9—Prescribed equipment (section 33LA)\n\t(1)\tFor the purposes of section 33LA of the Act—\n\t(a)\tthe following equipment (being equipment that is, or may at some stage have been, capable of being used for hydroponic cannabis cultivation) is prescribed:\n\t(i)\tmetal halide lights, high pressure sodium lights and mercury vapour lights of 400 watts or greater;\n\t(ia)\tlight‑emitting diode (LED) lights of 100 watts or greater;\n\t(ii)\tballast boxes;\n\t(iii)\tdevices (including control gear, lamp mounts and reflectors) designed to amplify light or heat;\n\t(iv)\tcarbon filters designed to filter air within a room, or from 1 area of a building to another or to outside;\n\t(v)\tcannabis bud or head strippers;\n\t(vi)\tunits designed to contain plants and rotate around a light source so that the plants grow hydroponically while being exposed to a consistent degree of light or heat or both; and\n\t(b)\tthe following equipment (being equipment that is, or may at some stage have been, capable of being used in the manufacture of controlled drugs) is prescribed:\n\t(i)\tcondensers;\n\t(ii)\tdistillation heads;\n\t(iii)\theating mantles;\n\t(iv)\trotary evaporators;\n\t(v)\theater‑stirrers;\n\t(vi)\tmechanical‑stirrers;\n\t(vii)\tpressure reaction vessels;\n\t(viii)\tseparatory funnels;\n\t(ix)\tbuchner flasks;\n\t(x)\tin‑line membrane filters;\n\t(xi)\treaction vessels;\n\t(xii)\tsplash heads;\n\t(xiii)\ttube furnaces;\n\t(xiv)\tmanual or mechanical tablet presses, including parts for such an item;\n\t(xv)\tmanual or mechanical encapsulators, including parts for such an item;\n\t(xvi)\tan item modified to perform the function of a condenser, distillation head, splash head, pressure reaction vessel or tube furnace; and\n\t(c)\ta device comprising a hydraulic compression system and a die that is, or may at some stage have been, capable of being used to compress a powdered substance into blocks is prescribed.\n\t(2)\tEquipment described in subregulation (1) is prescribed for the purposes of section 33LA of the Act regardless of whether the equipment is in working order or has been, or is being, modified in any way.\n10—Prescribed quantity of mixture containing controlled precursors (section 33LB)\nThe quantity of a mixture containing a particular controlled precursor prescribed for the purposes of section 33LB of the Act for any mixture containing the controlled precursor is the amount (if any) listed in the column headed \"Commercial (mixed)\" of the table in Schedule 2 opposite the entry listing the controlled precursor.\n11—Prescribed equipment (sections 33LB and 33J)\n\t(1)\tFor the purposes of sections 33LB(2)(b) and 33J(2)(b) of the Act—\n\t(a)\tthe following equipment (being equipment that is, or may at some stage have been, capable of being used in the manufacture of controlled drugs) is prescribed:\n\t(i)\tcondensers;\n\t(ii)\tdistillation heads;\n\t(iii)\theating mantles;\n\t(iv)\trotary evaporators;\n\t(v)\theater‑stirrers;\n\t(vi)\tmechanical‑stirrers;\n\t(vii)\tpressure reaction vessels;\n\t(viii)\tseparatory funnels;\n\t(ix)\tbuchner flasks;\n\t(x)\tin‑line membrane filters;\n\t(xi)\treaction vessels;\n\t(xii)\tsplash heads;\n\t(xiii)\ttube furnaces;\n\t(xiv)\tmanual or mechanical tablet presses, including parts for such an item;\n\t(xv)\tmanual or mechanical encapsulators, including parts for such an item;\n\t(xvi)\tan item modified to perform the function of a condenser, distillation head, splash head, pressure reaction vessel or tube furnace; and\n\t(b)\ta device comprising a hydraulic compression system and a die that is, or may at some stage have been, capable of being used to compress a powdered substance into blocks is prescribed.\n\t(2)\tEquipment described in subregulation (1) is prescribed for the purposes of sections 33LB and 33J of the Act regardless of whether the equipment is in working order or has been, or is being, modified in any way.\n12—No accessorial liability in prescribed circumstances\n\t(1)\tFor the purposes of section 33S of the Act, a circumstance consisting of the sale or supply of syringes or needles, or the giving of advice or instruction on the safe use of syringes or needles, by—\n\t(a)\ta medical practitioner; or\n\t(b)\ta pharmacist; or\n\t(c)\ta person acting in the course of a health risk minimisation program,\nis prescribed.\n\t(2)\tIn this regulation—\nhealth risk minimisation program means a program—\n\t(a)\tdesigned to facilitate—\n\t(i)\tthe supply to intravenous drug users of sterile syringes and sterile needles, and any associated equipment, to prevent the spread of infectious diseases and minimise health risks associated with intravenous drug use; and\n\t(ii)\tthe giving out of information concerning safe practices in the use of syringes and needles to prevent the spread of infectious diseases; and\n\t(b)\tdeclared by the Minister, by notice in writing given personally or by post to the person responsible for conducting the program, to be a health risk minimisation program for the purposes of this regulation.\n\t(3)\tThe Minister may, by subsequent notice in writing given personally or by post to the person responsible for conducting the program, vary or revoke the declaration.\n13—Prescribed place\nFor the purposes of section 44(1)(da) of the Act, a prescribed place is any place where members of the public are gathered for an entertainment or an event or activity of any kind, whether admission is open, procured by the payment of money or restricted to members of a club or a class of persons with some other qualification or characteristic.\n14—Expiation fees for simple cannabis offences\nIn accordance with section 45A(3) of the Act, the fees fixed for the expiation of simple cannabis offences are set out in Schedule 5.\n15—Simple cannabis offences\n\t(1)\tFor the purposes of paragraph (a) of the definition of simple cannabis offence in section 45A(8) of the Act, the prescribed number of cannabis plants is 1.\n\t(2)\tFor the purposes of paragraph (b) of the definition of simple cannabis offence in section 45A(8) of the Act, the following quantities of cannabis, cannabis resin and cannabis oil are prescribed:\n\t(a)\tin the case of cannabis—100 grams;\n\t(b)\tin the case of cannabis resin—20 grams;\n\t(c)\tin the case of cannabis oil—0 millilitres.\n\t(3)\tFor the purposes of paragraph (c) of the definition of simple cannabis offence in section 45A(8) of the Act, a motor vehicle, train, tram or any other vehicle is, while in a public place, prescribed.\n16—Taking of cannabis samples (section 52E(6))\n\t(1)\tFor the purposes of section 52E(6) of the Act, where samples of cannabis are to be taken, they must be taken as follows:\n\t(a)\tin the case of a crop of growing or newly harvested plants consisting of—\n\t(i)\t10 or fewer plants—at least 1 sample must be taken;\n\t(ii)\t11 to 20 plants—at least 5 samples must be taken;\n\t(iii)\t21 to 100 plants—at least 10 samples must be taken;\n\t(iv)\tmore than 100 plants—at least 20 samples must be taken;\n\t(b)\tin the case of dried and packaged cannabis, a sample of at least 10 grams must be taken from each package.\n\t(2)\tEach sample must be separately packaged and identified.\n\t(3)\tFor the purposes of this regulation—\nsamples, in relation to plants, means—\n\t(a)\tif the plants are immature (that is to say, they do not have any fully developed leaves) the plants themselves;\n\t(b)\tif the plants are mature, a fully developed leaf or flowerhead (taken from separate plants if more than one sample is required).\n17—Prescribed manner of initiation of analysis and prescribed fee\nFor the purposes of section 53(3) of the Act—\n\t(a)\tthe prescribed manner of initiating an analysis is by notice in writing, addressed to the analyst, describing the substance to be analysed and signed by the person initiating the analysis; and\n\t(b)\tthe prescribed fee for analysis is $207 per substance.\n18—Prescribed form of certificate of analysis (section 53(4))\nFor the purposes of section 53(4) of the Act, the form set out in Schedule 4 is the prescribed form for the certificate of analysis.\nSchedule 1—Controlled drugs\nPart 1—Controlled drugs other than drugs of dependence\n\n\nLarge commercial\nCommercial\nTrafficable\n\n(pure)\n(mixed)\n(pure)\n(mixed)\n(pure)\n(mixed)\nAcetorphine\n\n2 kg\n\n0.5 kg\n\n3 g\nAcetyl-alpha-\nmethylfentanyl\n\n0.005 kg\n\n0.00125 kg\n\n0.0075 g\nAcetyl fentanyl\n\n0.005 kg\n\n0.00125 kg\n\n0.0075 g\n3-(1-Adamantoyl)-indoles\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nN-(1-Adamantyl)-1-(5-\nfluoropentyl)-1H-indazole-3-\ncarboxamide (5F-AKB48)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nN-(Adamant-1-yl)-1-(5-\nfluoropentyl)-1H-indole-3-\ncarboxamide (STS-135)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nN-(1-Adamantyl)-indazole-3-\ncarboxamides\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nN-allyl-N-[2-(5-Methoxy-1H-\nindol-3-yl)ethyl]prop-2-en-1-\namine (N,N-diallyl-5-\nMethoxytryptamine or 5-MeO-DALT)\n\n1 kg or 100 DDUs\n\n0.2 kg or 20 DDUs\n\n2 g or 10 DDUs\nAllylprodine\n\n1 kg\n\n0.25 kg\n\n1.5 g\nAlphamethadol\n\n1 kg or 500 DDUs\n\n0.2 kg or 100 DDUs\n\n20 g or 50 DDUs\nAlpha-methylfentanyl\n\n0.005 kg\n\n0.00125 kg\n\n0.0075 g\nAlpha-methylthiofentanyl\n\n0.005 kg\n\n0.00125 kg\n\n0.0075 g\nAlpha-methyltryptamine\n(α-MT)\n\n1 kg or 100 DDUs\n\n0.2 kg or 20 DDUs\n\n2 g or 10 DDUs\nN-[1-Aminocarbonyl)-2-\nmethylpropyl]-1-\n(cyclohexylmethyl)-1H-\nindazole-3-carboxamide\n(AB-CHMINACA)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nN-[1-(Aminocarbonyl)-2-\nmethylpropyl]-1-[(4-\nfluorophenyl)methyl]-1H-\nindazole-3-carboxamide (AB-FUBINACA)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nN-[1-(Aminocarbonyl)-2-\nmethylpropyl]-1-pentyl-1H-\nindazole-3-carboxamide (AB-PINACA)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n5-(2-Aminopropyl)\nbenzofuran (5-APB)\n\n1 kg\n\n0.5 kg\n\n2 g\n6-(2-Aminopropyl)\nbenzofuran (6-APB)\n\n1 kg\n\n0.5 kg\n\n2 g\n5-(2-Aminopropyl)indan\n\n1 kg\n\n0.25 kg\n\n3 g\n3-(2-Aminopropyl)indole (AMT)\n\n0.2 kg\n\n0.05 kg\n\n5 g\nArylcyclohexylamines (not otherwise listed in this Schedule)\n\n2 kg or 100 DDUs\n\n0.5 kg or 20 DDUs\n\n6 g or 10 DDUs\nBenzethidine\n\n10 kg\n\n2.5 kg\n\n15 g\n1-(1,3-Benzodioxol-5-yl)-\n2-(ethylamino)pentan-1-\none (N-Ethylpentylone)\n\n1 kg\n\n0.5 kg\n\n2 g\n1-(1,3-Benzodioxol-5-yl)-2-\n(ethylamino)propan-1-one\n(Ethylone)\n\n1 kg\n\n0.5 kg\n\n2 g\n1-(1,3-Benzodioxol-5-yl)-2-\n(methylamino)butan-1-one\n(Butylone)\n\n1 kg\n\n0.5 kg\n\n2 g\n1-(1,3-Benzodioxol-5-yl)-2-\n(methylamino)pentan-1-one\n(Pentylone)\n\n1 kg\n\n0.5 kg\n\n2 g\nBenzoylecgonine\n\n1 kg\n\n0.25 kg\n\n3 g\nBenzoylindoles (not otherwise listed in this Schedule)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n2-Benzylbenzimidazoles\n\n0.005 kg or 100 DDUs\n\n0.00125 kg or 20 DDUs\n\n0.0075 g or 10 DDUs\n1-Benzylpiperazine (BZP)\n\n1 kg\n\n0.25 kg\n\n3 g\nBenzylpiperazines (not otherwise listed in this Schedule)\n\n1 kg\n\n0.25 kg\n\n3 g\nBeta-hydroxyfentanyl\n\n0.005 kg\n\n0.00125 kg\n\n0.0075 g\nBeta-hydroxy-3-\nmethylfentanyl\n\n0.005 kg\n\n0.00125 kg\n\n0.0075 g\nBetamethadol\n\n1 kg or 500 DDUs\n\n0.2 kg or 100 DDUs\n\n20 g or 50 DDUs\nBeta-phenyl-gamma-aminobutyric acid (Phenibut)\n\n1 kg\n\n0.5 kg\n\n20 g\nBetaprodine (excluding its stereoisomers)\n\n1 kg\n\n0.25 kg\n\n1.5 g\n4-Bromo-2,5-\ndimethoxyamphetamine\n\n0.2 kg\n\n0.05 kg\n\n5 g\n2-(4-Bromo-2,5-\ndimethoxyphenyl)-N-[(2-\nmethoxyphenyl)methyl]\nethanamine (25B-NBOMe)\n\n0.015 kg or 100 DDUs\n\n0.005 kg or 20 DDUs\n\n0.015 g or 10 DDUs\n1-(8-Bromobenzo[1,2-b:4,5-\nb]difuran-4-yl)-2-\naminopropane\n(Bromo-Dragonfly)\n\n100 DDUs\n\n20 DDUs\n\n10 DDUs\nBrorphine\n\n0.005 kg or 100 DDUs\n\n0.00125 kg or 20 DDUs\n\n0.0075 g or 10 DDUs\nBufotenine\n\n2 kg\n\n0.5 kg\n\n2 g\n1,4-Butanediol\n\n2 kg\n\n0.5 kg\n\n50 g\nButonitazene\n\n0.005 kg or 100 DDUs\n\n0.00125 kg or 20 DDUs\n\n0.0075 g or 10 DDUs\n1-Butyl-3-\n(1-naphthoyl)indole\n(JWH-073)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nButyryl fentanyl\n\n0.005 kg\n\n0.00125 kg\n\n0.0075 g\nCannabis except—\n2 kg\n12.5 kg\n1 kg\n2.5 kg\n250 g\n250 g\n\t(a)\twhen included in Schedule 4 or Schedule 8 of the Uniform Poisons Standard; or\n\n\n\n\n\n\n\t(b)\twhen it is, or is an ingredient in, a low THC cannabis food product; or\n\n\n\n\n\n\n\t(c)\tprocessed hemp fibre containing 0.1% or less of tetrahydrocannabinols (including hemp fibre products manufactured from such fibre);\n\n\n\n\n\n\nCannabis oil except—\n2 kg\n10 kg\n1 kg\n2 kg\n\n25 g\n\t(a)\twhen included in Schedule 4 or Schedule 8 of the Uniform Poisons Standard; or\n\n\n\n\n\n\n\t(b)\twhen it is, or is an ingredient in, a low THC cannabis food product; or\n\n\n\n\n\n\n\t(c)\themp seed oil containing cannabinoids at a level not exceeding 50 mg/kg that is for purposes other than internal human use.\n\n\n\n\n\n\nCannabis resin except—\n2 kg\n10 kg\n1 kg\n2 kg\n\n25 g\n\t(a)\twhen included in Schedule 4 or Schedule 8 of the Uniform Poisons Standard; or\n\n\n\n\n\n\n\t(b)\twhen it is, or is an ingredient in, a low THC cannabis food product.\n\n\n\n\n\n\nCathinones (not otherwise listed in this Schedule)\n0.75 kg\n1 kg\n0.1 kg\n0.5 kg\n\n2 g\n4-Chloro-2,5-\ndimethoxyamphetamine\n\n0.2 kg or 100 DDUs\n\n0.05 kg or 20 DDUs\n\n5 g or 10 DDUs\n2-(4-Chloro-2,5-\ndimethoxyphenyl)-N-[(2-\nmethoxyphenyl)methyl]\nethanamine (25C-NBOMe)\n\n0.015 kg or 100 DDUs\n\n0.005 kg or 20 DDUs\n\n0.015 g or 10 DDUs\n1-(3-\nChlorophenyl)piperazine\n\n1 kg\n\n0.25 kg\n\n3 g\nClonazolam\n\n1.5 kg or 100 DDUs\n\n0.6 kg or 20 DDUs\n\n30 g or 10 DDUs\nClonitazene\n\n0.005 kg or 100 DDUs\n\n0.00125 kg or 20 DDUs\n\n0.0075 g or 10 DDUs\nCodoxime\n\n10 kg\n\n2.5 kg\n\n15 g\n4-Cyano-2-dimethylamino-\n4,4-diphenylbutane\n(methadone intermediate)\n\n2 kg\n\n0.5 kg\n\n3 g\n1-Cyclohexylethyl-3-(2-\nmethoxyphenylacetyl)indole\n(RCS-8)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nCyclohexylphenols (not otherwise listed in this Schedule but not including 2-cyclohexylphenol)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nDeschloroetizolam\n\n1.5 kg or 100 DDUs\n\n0.6 kg or 20 DDUs\n\n30 g or 10 DDUs\nDesomorphine\n\n2 kg\n\n0.5 kg\n\n3 g\nN,N-Dialkylaminocyclohexyl alkyl benzamides (not otherwise listed in this Schedule)\n\n0.1 kg\n\n0.02 kg\n\n2 g\nN,N-Dialkylaminocyclohexylmethyl alkyl benzamides (not otherwise listed in this Schedule)\n\n0.1 kg\n\n0.02 kg\n\n2 g\nDiampromide\n\n5 kg\n\n1.25 kg\n\n7.5 g\nDibenzopyrans (not otherwise listed in this Schedule)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n3,4-dichloro-N-[1-\n(dimethylamino)\ncyclohexylmethyl]benzamide\n(AH-7921)\n\n1 kg\n\n0.2 kg\n\n20 g\n3,4-dichloro-N-[2-\n(dimethylamino)\ncyclohexyl]-N-methylbenzamide\n(U-47700)\n\n0.1 kg\n\n0.02 kg\n\n2 g\nDiclazepam\n\n1.5 kg or 100 DDUs\n\n0.6 kg or 20 DDUs\n\n30 g or 10 DDUs\n(3-Diethylamino-2,2-\ndimethylpropyl)-4-\naminobenzoate (Dimethocaine)\n\n1 kg\n\n0.2 kg\n\n2 g\nDiethylthiambutene\n\n5 kg\n\n1.25 kg\n\n7.5 g\nN,N-Diethyltryptamine\n\n1 kg or 100 DDUs\n\n0.2 kg or 20 DDUs\n\n2 g or 10 DDUs\n6,7-dihydro-5H-cyclopenta[f]\n[1,3]benzodioxol-6-amine (5,6-Methylenedioxy-2-\naminoindane or MDAI)\n\n1 kg\n\n0.5 kg\n\n2 g\nDihydrohydroxymorphine\n\n10 kg\n\n2.5 kg\n\n250 g\n2,5-Dihydro-2-(1-methyl-1-phenylethyl)-5-pentyl-1H-pyrido[4,3-b]indol-1-one (SGT-151) (cumyl-pegaclone)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nDimenoxadol\n\n10 kg\n\n2.5 kg\n\n125 g\nDimepheptanol\n\n10 kg\n\n2.5 kg\n\n125 g\n2,5-Dimethoxy-4-\nbromophenethylamine\n\n1 kg\n\n0.5 kg\n\n2 g\n2,5-Dimethoxy-4-\nchlorophenethylamine\n\n1 kg\n\n0.5 kg\n\n2 g\n2,5-Dimethoxy-4-\nethylthiophenethylamine\n\n1 kg\n\n0.5 kg\n\n2 g\n2,5-Dimethoxy-4-\niodophenethylamine\n\n1 kg\n\n0.5 kg\n\n2 g\n2,5-Dimethoxy-4-\nmethylphenethylamine\n\n1 kg\n\n0.5 kg\n\n2 g\n2-(2,5-Dimethoxyphenyl)\nethanamine (2C-H)\n\n1 kg\n\n0.5 kg\n\n2 g\n2-(2,5-Dimethoxyphenyl)-N-\n(2-methoxybenzyl)ethanamine\n(25H-NBOMe)\n\n0.015 kg or 100 DDUs\n\n0.005 kg or 20 DDUs\n\n0.015 g or 10 DDUs\n2,5-Dimethoxy-4-(N)-\npropylthiophenethylamine\n\n1 kg or 100 DDUs\n\n0.5 kg or 20 DDUs\n\n2 g or 10 DDUs\nN,N-Dimethyl-5-methoxy\ntryptamine (5-MeO-DMT)\n\n1 kg or 100 DDUs\n\n0.2 kg or 20 DDUs\n\n2 g or 10 DDUs\nN,N-Dimethylamphetamine\n\n1 kg\n\n0.5 kg\n\n2 g\n3-(1,2-Dimethylheptyl)-1-\nhydroxy-7,8,9,10-\ntetrahydro-6, 6,9-trimethyl-\n6h-dibenzo (b,d) pyran \n(DMHP)\n\n2 kg\n\n0.5 kg\n\n3 g\n5-(1,1-Dimethylheptyl)-2-\n[3-hydroxycyclohexyl]-phenol \n(CP-47,497)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n5-(1,1-Dimethyloctyl)-2-\n[3-hydroxycyclohexyl]-phenol\n(cannabicyclohexanol)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nDimethylthiambutene\n\n5 kg\n\n1.25 kg\n\n7.5 g\nN,N-Dimethyltryptamine\n\n2 kg or 100 DDUs\n\n0.5 kg or 20 DDUs\n\n3 g or 10 DDUs\nDioxaphetylbutyrate\n\n2 kg\n\n0.5 kg\n\n3 g\nN,N-Di-(N)-\npropyltryptamine (DPT)\n\n1 kg or 100 DDUs\n\n0.2 kg or 20 DDUs\n\n2 g or 10 DDUs\nEcgonine\n\n1 kg\n\n0.25 kg\n\n3 g\n2-ethylamino-1-(4-\nmethylphenyl)propan-1-one (4-methylethcathinone or 4-MEC)\n\n1 kg\n\n0.5 kg\n\n2 g\n4,5-Ethylenedioxy-3-\nmethoxyamphetamine\n\n1 kg\n\n0.5 kg\n\n2 g\nEthylmethylthiambutene\n\n5 kg\n\n1.25 kg\n\n7.5 g\n4-Ethylnaphthalen-1-yl-(1-\npentylindol-3-yl)\nmethanone (JWH-210)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nEticyclidine (PCE)\n\n0.004 kg\n\n0.001 kg\n\n0.0075 g\nEtodesnitazene, etazene\n\n0.005 kg or 100 DDUs\n\n0.00125 kg or 20 DDUs\n\n0.0075 g or 10 DDUs\nEtonitazene\n\n0.005 kg or 100 DDUs\n\n0.00125 kg or 20 DDUs\n\n0.0075 g or 10 DDUs\nEtonitazepipne\n\n0.005 kg or 100 DDUs\n\n0.00125 kg or 20 DDUs\n\n0.0075 g or 10 DDUs\nEtorphine\n\n5 kg\n\n1.25 kg\n\n7.5 g\nEtoxeridine\n\n5 kg\n\n1.25 kg\n\n7.5 g\nN-(1-Fenchyl)-indole-3-\ncarboxamides\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nFenethylline\n\n2 kg\n\n0.5 kg\n\n3 g\nFentanyls (not otherwise listed in this Schedule)\n\n0.005 kg\n\n0.00125 kg\n\n0.0075 g\nFlubromazepam\n\n1.5 kg or 100 DDUs\n\n0.6 kg or 20 DDUs\n\n30 g or 10 DDUs\nFlubromazolam\n\n1.5 kg or 100 DDUs\n\n0.6 kg or 20 DDUs\n\n30 g or 10 DDUs\nFlunitazene\n\n0.005 kg or 100 DDUs\n\n0.00125 kg or 20 DDUs\n\n0.0075 g or 10 DDUs\n2-(4-Fluoro-2,5-\ndimethoxyphenyl)-1-\naminoethane (2C-F)\n\n1 kg\n\n0.5 kg\n\n2 g\n2-(4-Fluoro-2,5-\ndimethoxyphenyl)-N-\n(2-methoxybenzyl)ethanamine \n(25F-NBOMe)\n\n0.015 kg or 100 DDUs\n\n0.005 kg or 20 DDUs\n\n0.015 g or 10 DDUs\n4-Fluoro-N-\nmethylamphetamine\n\n1 kg\n\n0.5 kg\n\n2 g\n(1-(5-Fluoropentyl)-1H-\nindol-3-yl)(2,2,3,3-\ntetramethylcyclopropyl)\nmethanone (XLR-11)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n1-(5-Fluoropentyl)-3-\n(2-iodobenzoyl)indole\n(AM-694)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n1-(5-Fluoropentyl)-3-\n(1-naphthoyl)indole\n(AM-2201)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nFuranyl fentanyl\n\n0.005 kg\n\n0.00125 kg\n\n0.0075 g\nFurethidine\n\n1 kg\n\n0.25 kg\n\n1.5 g\nHarmaline\n\n5 kg\n\n1.25 kg\n\n20 g\nHarmine\n\n5 kg\n\n1.25 kg\n\n20 g\nHarmines (not otherwise listed in this Schedule)\n\n5 kg\n\n1.25 kg\n\n20 g\nHeroin (diacetylmorphine/\ndiamorphine)\n0.75 kg\n1 kg\n0.1 kg\n0.2kg\n\n2 g\n3-Hexyl-1-hydroxy-\n7,8,9,10-tetrahydro-6,6,9-\ntrimethyl-6H-dibenzo\n(b,d)pyran\n4 kg\n25 kg\n1 kg\n10 kg\n\n25 g\n1-Hexyl-3-\n(1-naphthoyl)indole\n(JWH-019)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nHydroxyamphetamine\n\n5 kg\n\n1.25 kg\n\n6 g\n4-Hydroxybutanoic acid (GHB)\n\n2 kg\n\n0.5 kg\n\n50 g\n4-Hydroxybutanoic acid lactone (GBL)\n\n2 kg\n\n0.5 kg\n\n50 g\nHydroxyfentanyl\n\n0.005 kg\n\n0.00125 kg\n\n0.0075 g\n9-(Hydroxymethyl)-6,6-\ndimethyl-3-(2-methyloctan-\n2-yl)-6a,7,10,10a-\ntetrahydrobenzo[c]chromen-\n1-ol (HU-210)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nHydroxy-3-methylfentanyl\n\n0.005 kg\n\n0.00125 kg\n\n0.0075 g\nHydroxypethidine\n\n1 kg\n\n0.25 kg\n\n3 g\nIndazole-3-carboxamides\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nIndole-3-carboxylic acid, quinolinyl esters\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n(Indol-3-yl)-(2,2,3,3-tetra-\nalkylcyclopropyl)methanones\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n4-Iodo-2,5-dimethoxy\namphetamine\n\n0.2 kg or 100 DDUs\n\n0.05 kg or 20 DDUs\n\n5 g or 10 DDUs\n2-(4-Iodo-2,5-\ndimethoxyphenyl)-N-[(2-\nmethoxyphenyl)methyl]\nethanamine (25I-NBOMe)\n\n0.015 kg or 100 DDUs\n\n0.005 kg or 20 DDUs\n\n0.015 g or 10 DDUs\nIsomethadone\n\n2 kg\n\n0.5 kg\n\n3 g\nIsotonitazene\n\n0.005 kg or 100 DDUs\n\n0.00125 kg or 20 DDUs\n\n0.0075 g or 10 DDUs\nKetobemidone\n\n2 kg\n\n0.5 kg\n\n3 g\nLevomethorphan (excluding its stereoisomers)\n\n2 kg\n\n0.5 kg\n\n3 g\nLysergamide\n\n0.015 kg\n\n0.005 kg\n\n0.015 g\nLysergic acid\n\n0.015 kg\n\n0.005 kg\n\n0.015 g\nLysergic acid diethylamide (LSD)\n\n0.015 kg or 100 DDUs\n\n0.005 kg or 20 DDUs\n\n0.015 g or 10 DDUs\nMeclonazepam\n\n1.5 kg or 100 DDUs\n\n0.6 kg or 20 DDUs\n\n30 g or 10 DDUs\nMecloqualone\n\n5 kg\n\n1.25 kg\n\n15 g\nMeprodine\n\n1 kg\n\n0.25 kg\n\n1.5 g\nMescaline (3,4,5-\nTrimethoxyphenethylamine)\n\n0.2 kg\n\n0.05 kg\n\n2 g\nMetazocine\n\n7 kg\n\n1.75 kg\n\n125 g\nMethaqualone\n\n5 kg\n\n1.25 kg\n\n7.5 g\nMethcathinone\n0.75 kg\n1 kg\n0.1 kg\n0.5 kg\n\n2g\nMethcathinones (not otherwise listed in this Schedule)\n0.75 kg\n1 kg\n0.1 kg\n0.5 kg\n\n2g\n5-Methoxy-α-\nmethyltryptamine\n\n0.2 kg or 100 DDUs\n\n0.05 kg or 20 DDUs\n\n5 g or 10 DDUs\n7-Methoxy-1-(2-\nmorpholinoethyl)-N-1,3,3-\ntrimethylbicyclo[2.2.1]heptan-\n2-yl)-1H-indole-3-\ncarboxamide (N-Fenchyl-1-(2-\nmorpholinoethyl)-7-\nmethoxyindole-3-\ncarboxamide or UR-12)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n4-Methoxyphenyl(1-butyl-\n1H-indol-3-yl)-methanone\n(RCS-4 (C4))\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n2-(3-Methoxyphenyl)-2-\n(ethylamino)cyclohexanone (Methoxetamine)\n\n2 kg or 100 DDUs\n\n0.5 kg or 20 DDUs\n\n6 g or 10 DDUs\n2-(4-Methoxyphenyl)-1-\n(1-pentyl-1H-indol-3-yl)-\nethanone (JWH-201)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n2-(3-Methoxyphenyl)-1-(1-\npentylindol-3-yl)ethanone\n(JWH-302)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n1-(4-\nMethoxyphenyl)piperazine\n\n1 kg\n\n0.25 kg\n\n3 g\n4-Methylaminorex\n1 kg\n2.5 kg\n0.25 kg\n1.25 kg\n\n6 g\nN-Methyl-1-(1,3-\nbenzodioxol-\n5-yl)-2-butanamine \n(MBDB)\n\n0.75 kg\n\n0.1 kg\n\n2 g\nmethyl 2-(1-(cyclohexylmethyl)-1\nH-indole-3-carboxamido) -3,3-dimethylbutanoate (MDMB-CHMICA)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nMethyldesorphine\n\n2 kg\n\n0.5 kg\n\n3 g\n4-Methyl-2,5-dimethoxy\namphetamine\n\n1 kg or 100 DDUs\n\n0.5 kg or 20 DDUs\n\n2 g or 10 DDUs\n3,4-Methylenedioxy\namphetamine (MDA)\n0.75 kg\n1 kg\n0.1 kg\n0.5 kg\n\n2 g\n3,4-Methylenedioxy-N-ethyl\namphetamine (MDEA)\n0.75 kg\n1 kg\n0.1 kg\n0.5 kg\n\n2 g\n3,4-Methylenedioxy\nmethcathinone\n0.75 kg\n1 kg\n0.1 kg\n0.5 kg\n\n2 g\n3,4-Methylenedioxymethyl\namphetamine (MDMA) (except when included in Schedule 8 of the Uniform Poisons Standard)\n0.75 kg\n1 kg\n0.1 kg\n0.5 kg\n\n2 g\n3,4-Methylenedioxy\npyrovalerone (MDPV)\n0.75 kg\n1 kg\n0.1 kg\n0.5 kg\n\n2 g\n3-Methylfentanyl\n\n0.005 kg\n\n0.00125 kg\n\n0.0075 g\n4-Methylmethcathinone (Mephedrone)\n0.75 kg\n1 kg\n0.1 kg\n0.5 kg\n\n2 g\n2-Methyl-3-morpholino-1,1-\ndiphenylpropane carboxylic acid (Moramide intermediate)\n\n2 kg\n\n0.5 kg\n\n3 g\n1-Methyl-4-phenyl-4-\npropionoxypiperidine\n\n1 kg\n\n0.25 kg\n\n3 g\n1-(4-methylphenyl)-2-(1-\npyrrolidinyl)-1-propanone (4’-Methyl-α-\npyrrolidinopropiophenone\nor 4-MePPP or MαPPP)\n\n1 kg\n\n0.5 kg\n\n2 g\n1-[(N-Methylpiperidin-2-yl)\nmethyl]-3-(2-iodobenzoyl)\nindole (AM-2233)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n(2-Methyl-1-propyl-1H-\nindol-3-yl)-1-\nnaphthalenylmethanone\n(JWH-015)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n3-Methylthiofentanyl\n\n0.005 kg\n\n0.00125 kg\n\n0.0075 g\nMetodesnitazene\n\n0.005 kg or 100 DDUs\n\n0.00125 kg or 20 DDUs\n\n0.0075 g or 10 DDUs\nMetonitazene\n\n0.005 kg or 100 DDUs\n\n0.00125 kg or 20 DDUs\n\n0.0075 g or 10 DDUs\nMetopon\n\n2 kg\n\n0.5 kg\n\n3 g\nMitragynine\n\n\n\n\n\n\nMonoacetylmorphine\n\n1.5 kg\n\n0.6 kg\n\n30 g\nMorpheridine\n\n1.5 kg\n\n0.6 kg\n\n30 g\nMorphinone\n\n1.5 kg\n\n0.6 kg\n\n30 g\n1-[2-(4-Morpholinyl)ethyl]-\n3-(1-naphthoyl)indole \n(JWH-200)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nMuscimol\n\n2 kg\n\n0.5 kg\n\n125 g\nMyrophine\n\n20 kg\n\n5 kg\n\n30 g\nNaphthalen-1-yl 1-\n(5-fluoropentyl)-1H-indole-3-\ncarboxylate (NM2201)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nNaphthoylindoles (not otherwise listed in this Schedule)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nNaphthoylpyrroles (not otherwise listed in this Schedule)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nNaphthylmethylindenes (not otherwise listed in this Schedule)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nNaphthylmethylindoles (not otherwise listed in this Schedule)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nNicocodine\n\n4 kg\n\n1 kg\n\n500 g\nNicodicodine\n\n4 kg\n\n1 kg\n\n500 g\nNicomorphine\n\n4 kg\n\n1 kg\n\n500 g\nNifoxipam\n\n1.5 kg or 100 DDUs\n\n0.6 kg or 20 DDUs\n\n30 g or 10 DDUs\nNoracymethadol\n\n1 kg or 500 DDUs\n\n0.2 kg or 100 DDUs\n\n20 g or 50 DDUs\nNorlevorphanol\n\n1 kg\n\n0.25 kg\n\n1.5 g\nNormorphine\n\n20 kg\n\n5 kg\n\n30 g\nNorpipanone\n\n10 kg\n\n2.5 kg\n\n15 g\nOcfentanil\n\n0.005 kg\n\n0.00125 kg\n\n0.0075 g\nOpium (except where it is a drug of dependence)\n\n4 kg\n\n1 kg\n\n30 g\nPara-fluorobutyryl fentanyl\n\n0.005 kg\n\n0.00125 kg\n\n0.0075 g\nParafluorofentanyl\n\n0.005 kg\n\n0.00125 kg\n\n0.0075 g\nParahexyl\n\n0.2 kg\n\n0.05 kg\n\n5 g\nParamethoxyamphetamine\n(4-Methoxyamphetamine or PMA)\n0.75 kg\n1 kg\n0.1 kg\n0.5 kg\n\n2 g\nParamethoxymeth\namphetamine (PMMA)\n0.75 kg\n1 kg\n0.1 kg\n0.5 kg\n\n2 g\n1-Pentyl-3-(Adamant-1-\noyl)indole (AB-001)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n1-Pentyl-3-(4-chloro-1-\nnaphthoyl)indole\n(JWH-398)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n1-Pentyl-3-(2-\nchlorophenylacetyl)indole (JWH-203)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n(1-Pentylindol-3-yl)\nnaphthalen-1-ylmethane\n(JWH-175)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n(1-Pentylindol-3-yl)-\n(2,2,3,3-tetramethyl\ncyclopropyl)methanone\n(UR-144)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n1-Pentyl-3-[(4-methoxy)-\nbenzoyl]indole (RCS-4)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n1-Pentyl-3-[1-(4-\nmethoxynaphthoyl)indole\n(JWH-081)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n1-Pentyl-3-(2-\nmethoxyphenylacetyl)indole\n(JWH-250)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n1-Pentyl-3-(4-methyl-1-\nnaphthoyl)indole\n(JWH-122)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n1-Pentyl-3-(1-naphthoyl)\nindole (JWH-018)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n1-Pentyl-N-\ntricyclo[3.3.1.13,7]dec-1-yl-\n1H-indazole-3-carboxamide\n(APINACA or AKB48)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n1-pentyl-N-\ntricyclo[3.3.1.13,7]dec-1-yl-\n1H-indole-3-carboxamide\n(N-(1-Adamantyl)\n-1-pentyl-1H-indole-3-\ncarboxamide or SDB-001 or APICA)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nPhenacylmorphan\n\n4 kg\n\n1 kg\n\n250 g\nPhenadoxone\n\n10 kg\n\n2.5 kg\n\n15 g\nPhenampromide\n\n10 kg\n\n2.5 kg\n\n15 g\nPhenazocine\n\n1 kg\n\n0.25 kg\n\n1.5 g\nPhencyclidine\n\n0.004 kg\n\n0.001 kg\n\n0.0075 g\nPhenethylamines (not otherwise listed in this Schedule)\n0.75kg\n1 kg\n0.1kg\n0.5 kg\n\n2 g\nPhenomorphan\n\n5 kg\n\n1.25 kg\n\n7.5 g\nPhenylacetylindoles (not otherwise listed in this Schedule)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\n1-Phenylethyl-4-\nacetoxypiperidine\n\n0.004 kg\n\n0.001 kg\n\n0.0075 g\n1-(2-Phenylethyl)-4-phenyl-\n4-acetyloxypiperidine\n(PEPAP)\n\n\n\n\n\n\n1-Phenyl-2-\n(methylamino)pentan-1-one\n(pentedrone)\n\n1 kg\n\n0.5 kg\n\n2 g\n1-phenyl-2-(1-\npyrrolidinyl)-1-pentanone\n(alpha-PVP or alpha pyrrolidinovalerophenone)\n\n1 kg\n\n0.5 kg\n\n2 g\nPiminodine\n\n10 kg\n\n2.5 kg\n\n15 g\nPiperazines (not otherwise listed in this Schedule)\n\n1 kg\n\n0.25 kg\n\n3 g\nPravadoline (WIN 48098)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nProheptazine\n\n1 kg\n\n0.25 kg\n\n1.5 g\nProperidine\n\n28 kg\n\n7 kg\n\n40 g\nPropoxyphene\n\n2 kg\n\n0.5 kg\n\n250 g\nProtonitazene\n\n0.005 kg or 100 DDUs\n\n0.00125 kg or 20 DDUs\n\n0.0075 g or 10 DDUs\nPsilocin (3-(2-\nDimethylaminoethyl)-4-\nhydroxyindole)\n\n1 kg\n\n0.25 kg\n\n100 g\nPsilocybine (Psilocybin) (except when included in Schedule 8 of the Uniform Poisons Standard)\n\n1 kg or 100 DDUs\n\n0.25 kg or 20 DDUs\n\n100 g or 10 DDUs\nPyrazolam\n\n1.5 kg or 100 DDUs\n\n0.6 kg or 20 DDUs\n\n30 g or 10 DDUs\nPyrovalerone (except when included in Schedule 4 of the Uniform Poisons Standard)\n0.75 kg\n1 kg\n0.1 kg\n0.5 kg\n\n2 g\nPyrovalerones (not otherwise listed in this Schedule) \n0.75 kg\n1 kg\n0.1 kg\n0.5 kg\n\n2 g\nN-pyrrolidino etonitazene, etonitazepyne\n\n0.005 kg or 100 DDUs\n\n0.00125 kg or 20 DDUs\n\n0.0075 g or 10 DDUs\nQuinolin-8-yl 1-(5-fluoropentyl)-\n1H-indole-3-\ncarboxylate (5F-PB-22)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nQuinolin-8-yl 1-pentyl-1H-\nindole-3-carboxylate (PB-22)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nRolicyclidine (PHP or PCPY)\n\n0.004 kg\n\n0.001 kg\n\n0.0075 g\nSalvinorin A\n\n0.2 kg\n\n0.05 kg\n\n5 g\nSynthetic cannabinomimetics (not otherwise listed in this Schedule)\n\n12.5 kg or 100 DDUs\n\n2.5 kg or 20 DDUs\n\n250 g or 10 DDUs\nTenocyclidine (TCP)\n\n0.004 kg\n\n0.001 kg\n\n0.0075 g\nTetrahydrocannabinols except—\n2 kg\n12.5 kg\n1 kg\n2.5 kg\n\n250 g\n\t(a)\twhen included in Schedule 4 or Schedule 8 of the Uniform Poisons Standard; or\n\n\n\n\n\n\n\t(b)\twhen contained in a low THC cannabis food product;\n\n\n\n\n\n\n\t(c)\twhen contained in processed hemp fibre containing 0.1 per cent or less of tetrahydrocannabinols (including hemp fibre products manufactured from such fibre); or\n\n\n\n\n\n\n\t(d)\twhen contained at a level not exceeding 50 mg/kg in hemp seed oil (or a product containing hemp seed oil) labelled with 1 or both of the following:\n\"Not for internal use\"\n\"Not to be taken\"\n\n\n\n\n\n\nThiambutene\n\n5 kg\n\n1.25 kg\n\n7.5 g\nThiofentanyl\n\n0.005 kg\n\n0.00125 kg\n\n0.0075 g\n1-(Thiophen-2-yl)-2-\nmethylaminopropane (methiopropamine)\n\n1 kg\n\n0.5 kg\n\n2 g\n1-(3-Trifluoromethylphenyl)\npiperazine (TFMPP)\n\n1 kg\n\n0.25 kg\n\n3 g\nTrimeperidine\n\n10 kg\n\n2.5 kg\n\n15 g\nTryptamines (not otherwise listed in this Schedule)\n\n1 kg or 100 DDUs\n\n0.2 kg or 20 DDUs\n\n2 g or 10 DDUs\nU‑48800\n\n0.1 kg\n\n0.02 kg\n\n2 g\nPart 2—Drugs of dependence\n\n\nLarge commercial\nCommercial\nTrafficable\n\n(pure)\n(mixed)\n(pure)\n(mixed)\n(mixed)\nAcetyldihydrocodeine\n\n10 kg\n\n2.5 kg\n15 g\nAcetylmethadol\n\n5 kg\n\n1.25 kg\n15 g\nAcetylmorphines (except monoacetylmorphine and heroin (diacetylmorphine/diamorphine))\n\n\n\n\n\nAlfentanil\n\n2 kg\n\n0.5 kg\n3 g\nAlphacetylmethadol\n\n\n\n\n\nAlphaprodine\n\n\n\n\n\nAlprazolam\n\n1.5 kg or 1000 DDUs\n\n0.6 kg or 200 DDUs\n30 g or 100 DDUs\nAmphetamine\n0.75 kg\n1 kg\n0.1 kg\n0.5 kg\n2 g\nAmphetamines (not otherwise listed in this Schedule)\n\n1 kg\n\n0.5 kg\n2 g\nAmylobarbitone (except when included in Schedule 4 of the Uniform Poisons Standard)\n\n4 kg\n\n1 kg\n125 g\nAnileridine\n\n10 kg\n\n2.5 kg\n15 g\nBenzylmorphine\n(3-benzylmorphine)\n\n5 kg\n\n1.25 kg\n7.5 g\nBezitramide\n\n5 kg\n\n1.25 kg\n7.5 g\nBuprenorphine\n\n0.04 kg\n\n0.01 kg\n0.06 g\nButobarbitone\n\n4 kg\n\n1 kg\n125 g\nButorphanol\n\n2 kg\n\n0.5 kg\n3 g\nCarfentanyl\n\n0.005 kg\n\n0.00125 kg\n0.0075 g\nCocaine\n0.75 kg\n1 kg\n0.1 kg\n0.2 kg\n2 g\nCodeine (except when included in Schedule 2, Schedule 3 or Schedule 4 of the Uniform Poisons Standard)\n\n2 kg\n\n0.5 kg\n125 g\nCodeine-N-oxide\n\n10 kg\n\n2.5 kg\n15 g\n4-Cyano-1-methyl-4-phenylpiperidine (pethidine intermediate A)\n\n1 kg\n\n0.25 kg\n3 g\nCyclobarbitone\n\n4 kg\n\n1 kg\n125 g\nDexamphetamine\n\n1 kg\n\n0.5 kg\n2 g\nDextromoramide\n\n1.5 kg\n\n0.6 kg\n30 g\nDextropropoxyphene (except when included in Schedule 4 of the Uniform Poisons Standard)\n\n\n\n\n\nDifenoxin (except when included in Schedule 4 of the Uniform Poisons Standard)\n\n2 kg\n\n0.5 kg\n100 g\nDihydrocodeine (except when included in Schedule 2, Schedule 3 or Schedule 4 of the Uniform Poisons Standard)\n\n10 kg\n\n2.5 kg\n250 g\nDihydromorphine\n\n10 kg\n\n2.5 kg\n250 g\nDiphenoxylate (except when included in Schedule 3 or Schedule 4 of the Uniform Poisons Standard)\n\n2 kg\n\n0.5 kg\n125 g\nDipipanone\n\n10 kg\n\n2.5 kg\n125 g\nDronabinol (delta-9- tetrahydrocannabinol) when prepared and packed for therapeutic use\n4 kg\n25 kg\n1 kg\n10 kg\n25 g\nDrotebanol\n\n1 kg\n\n0.25 kg\n3 g\nEthylamphetamine\n\n1 kg\n\n0.5 kg\n2 g\nEthylmorphine (except when included in Schedule 2 or Schedule 4 of the Uniform Poisons Standard)\n\n2 kg\n\n0.5 kg\n3 g\nFentanyl\n\n0.005 kg\n\n0.00125 kg\n0.0075 g\nFlunitrazepam\n\n1.5 kg or 1000 DDUs\n\n0.6 kg or 200 DDUs\n30 g or 100 DDUs\nHydrocodone\n\n2 kg\n\n0.5 kg\n3 g\nHydromorphinol\n\n2 kg\n\n0.5 kg\n3 g\nHydromorphone\n\n2 kg\n\n0.5 kg\n3 g\nKetamine\n\n2 kg\n\n0.5 kg\n6 g\nLevomoramide\n\n\n\n\n\nLevorphanol (excluding its stereoisomers)\n\n1 kg\n\n0.25 kg\n1.5 g\nLisdexamfetamine\n\n1 kg\n\n0.5 kg\n10 g\nMethadone\n\n20 kg\n\n4 kg\n400 g\n1-Methyl-4-phenylpiperidine-4-\ncarboxylic acid (pethidine intermediate C)\n\n1 kg\n\n0.25 kg\n3 g\nMethylamphetamine (Methamphetamine)\n0.75 kg\n1 kg\n0.1 kg\n0.5 kg\n2 g\nMethyldihydromorphine\n\n2 kg\n\n0.5 kg\n3 g\n3,4-Methylenedioxymethyl amphetamine (MDMA) in preparations for human therapeutic use for the treatment of post-traumatic stress disorder\n0.75 kg\n1 kg\n0.1 kg\n0.5 kg\n2 g\nMethylphenidate\n\n2 kg\n\n0.5 kg\n3 g\nMorphine\n\n1 kg or 500 DDUs\n\n0.2 kg or 100 DDUs\n20 g or 50 DDUs\nMorphine methobromide\n\n1.5 kg\n\n0.6 kg\n30 g\nMorphine-N-oxide\n\n1.5 kg\n\n0.6 kg\n30 g\nNabilone\n\n0.4 kg\n\n0.1 kg\n0.6 g\nNabiximols (botanical extract of cannabis sativa that includes the following cannabinoids: tetrahydrocannabinols, cannabidiol, cannabinol, cannabigerol, cannabichromene, cannabidiolic acid, tetrahydrocannabinolic acids, tetrahydrocannabivarol, and cannabidivarol, where tetrahydrocannabinols and cannabidiol (in approximately equal proportions) comprise not less than 90 per cent of the total cannabinoid content) in a buccal spray for human therapeutic use.\n\n12.5 kg\n\n2.5 kg\n250 g\nNorcodeine\n\n4 kg\n\n1 kg\n500 g\nNormethadone\n\n5 kg\n\n1.25 kg\n7.5 g\nOpium (except the alkaloids noscapine when included in Schedule 2 of the Uniform Poisons Standard and papaverine when included in Schedule 2 or Schedule 4 of the Uniform Poisons Standard)\n\n4 kg\n\n1 kg\n30 g\nOxycodone\n\n1 kg or 500 DDUs\n\n0.2 kg or 100 DDUs\n7.5 g or 50 DDUs\nOxymorphone\n\n2 kg\n\n0.5 kg\n3 g\nPentazocine\n\n5 kg\n\n1.25 kg\n125 g\nPentobarbitone (except when included in Schedule 4 of the Uniform Poisons Standard)\n\n4 kg\n\n1 kg\n125 g\nPethidine\n\n1 kg\n\n0.2 kg\n20 g\nPhendimetrazine\n\n10 kg\n\n2.5 kg\n15 g\nPhenmetrazine\n\n5 kg\n\n1.25 kg\n7.5 g\nPhenoperidine\n\n5 kg\n\n1.25 kg\n7.5 g\n4-Phenylpiperidine-4-carboxylic acid ethyl ester (pethidine intermediate B)\n\n1 kg\n\n0.25 kg\n3 g\nPholcodine (except when included in Schedule 2 or Schedule 4 of the Uniform Poisons Standard)\n\n5 kg\n\n1.25 kg\n7.5 g\nPiritramide\n\n1 kg\n\n0.25 kg\n1.5 g\nConcentrate of poppy straw\n\n\n\n\n\nPropiram\n\n2 kg\n\n0.5 kg\n3 g\nPsilocybine (Psilocybin) in preparations for human therapeutic use for the treatment of treatment-resistant depression\n\n1 kg or 100 DDUs\n\n0.25 kg or 20 DDUs\n100 g or 10 DDUs\nQuinalbarbitone\n\n4 kg\n\n1 kg\n125 g\nRacemoramide\n\n\n\n\n\nRemifentanil\n\n0.2 kg\n\n0.05 kg\n0.3 g\nSecbutobarbitone\n\n4 kg\n\n1 kg\n125 g\nSodium oxybate\n\n2 kg\n\n0.5 kg\n50 g\nSufentanil\n\n0.005 kg\n\n0.00125 kg\n0.0075 g\nTapentadol\n\n1 kg or 500 DDUs\n\n0.2 kg or 100 DDUs\n20 g or 50 DDUs\nThebacon\n\n2 kg\n\n0.5 kg\n3 g\nThebaine\n\n2 kg\n\n0.5 kg\n3 g\nTilidine\n\n1 kg\n\n0.25 kg\n3 g\nSchedule 2—Controlled precursors\n\n\nLarge commercial\n(mixed)\nCommercial\n(mixed)\nAcetaldehyde\n2 kg\n0.5 kg\nAcetic anhydride\n4 L\n1 L\nN-Acetylanthranilic acid\n20 kg\n5 kg\nAllylbenzene\n1 L\n0.25 L\nAllylpyrocatechol\n0.4 L\n0.1 L\nAlpha-phenylacetoacetonitrile\n2 kg\n0.5 kg\n4-Aminobutanoic acid\n6 kg\n1.5 kg\nAmmonia\n6 kg\n1.5 kg\nAmmonium formate\n2 kg\n0.5 kg\nAnethole\n0.4 L\n0.1 L\n4-anilino-N-phenethylpiperidine (ANPP)\n0.005 kg\n0.00125 kg\nAnthranilic acid\n20 kg\n5 kg\nBenzaldehyde\n2 L\n0.5 L\n1,3-Benzodioxole\n1 L\n0.25 L\nBenzyl bromide\n2 L\n0.5 L\nBenzyl chloride\n2 L\n0.5 L\nBoron tribromide\n1 L\n0.25 L\nBromobenzene\n2 L\n0.5 L\n5-Bromo-1,3-benzodioxole\n1 L\n0.25 L\nBromosafrole\n0.2 L\n0.05 L\n1,4-Butanediol\n2 kg\n0.5 kg\nCalcium\n1 kg\n0.25 kg\n1-Chlorophenyl-2-aminopropane\n1 kg\n0.25 kg\nChromic acid\n0.4 L\n0.1 L\nChromium trioxide\n0.4 kg\n0.1 kg\nEphedrine\n1 kg\n0.25 kg\nErgometrine\n0.0002 kg\n0.00005 kg\nErgotamine\n0.02 kg\n0.005 kg\nEthanamine\n2 L\n0.5 L\nEthyl phenyl acetate\n2 kg\n0.5 kg\nN-Ethylephedrine\n1 kg\n0.25 kg\nN-Ethylpseudoephedrine\n1 kg\n0.25 kg\nEugenol\n0.4 L\n0.1 L\nFormaldehyde\n6 kg\n1.5 kg\nFormamide\n2 L\n0.5 L\nHydriodic acid\n4 L\n1 L\nHydrobromic acid\n1 L\n0.25 L\nHydrogen\n6 kg\n1.5 kg\nHydrogen chloride\n6 kg\n1.5 kg\nHydrogen sulfide\n6 kg\n1.5 kg\n4-Hydroxybutanal\n6 L\n1.5 L\n4-Hydroxybutanoic acid lactone\n2 kg\n0.5 kg\n4-Hydroxybutanoic acid nitrile\n6 L\n1.5 L\n4-Hydroxypentanoic acid\n6 L\n1.5 L\n2-Hydroxytetrahydrofuran\n6 L\n1.5 L\nHypophosphite salts\n1 kg\n0.25 kg\nHypophosphorous acid\n1 L\n0.25 L\nIodine\n1 kg\n0.25 kg\nIsosafrole\n0.4 L\n0.1 L\nLithium\n1 kg\n0.25 kg\nLithium aluminium hydride\n0.2 kg\n0.05 kg\nLysergic acid\n0.0002 kg\n0.00005 kg\nMagnesium\n1 kg\n0.25 kg\nMandellic acid\n2 kg\n0.5 kg\nMercuric chloride\n0.004 kg\n0.001 kg\nMercury\n0.004 kg\n0.001 kg\nMethcathinone\n1 kg\n0.25kg\nMethylamine\n2 L\n0.5 L\nMethylammonium salts\n1 kg\n0.25 kg\nMethyl 3-[3'4'(methylene dioxy)phenyl]-2-\nmethyl glycidate (MMDMG)\n0.4 L\n0.1 L\n3,4-Methylenedioxyphenylacetic acid\n0.4 kg\n0.1 kg\n3,4-Methylenedioxyphenylpropan-2-one (PMK)\n1 L\n0.25 L\nN-Methylformamide\n2 L\n0.5 L\nN-Methylephedrine\n1 kg\n0.25 kg\nMethyl phenylacetate\n2 kg\n0.5 kg\nN-Methylpseudoephedrine\n1 kg\n0.25 kg\nTrans β-Methylstyrene\n2 L\n0.5 L\nNitroethane\n2 L\n0.5 L\nNitromethane\n2 L\n0.5 L\nNorpseudoephedrine\n1 kg\n0.25 kg\nPalladium\n0.02 kg\n0.005 kg\nN-Phenethyl-4-piperidone (NPP)\n0.005 kg\n0.00125 kg\nPhenylacetamide\n2 kg\n0.5 kg\nPhenylacetic acid\n2 kg\n0.5 kg\nPhenylacetonitrile\n2 L\n0.5 L\nPhenylacetyl chloride\n2 L\n0.5 L\nPhenylalanine\n2 kg\n0.5 kg\n1-Phenyl-2-bromopropane\n2 kg\n0.5 kg\n1-Phenyl-2-chloropropane\n2 kg\n0.5 kg\n1-Phenyl-2-iodopropane\n2 kg\n0.5 kg\n1-Phenyl-2-nitropropene\n1 kg\n0.25 kg\nPhenylpropanolamine\n2 kg\n0.5 kg\n1-Phenyl-2-propanol\n1 L\n0.25 L\n1-Phenyl-1-Propanone\n1 L\n0.25 L\n1-Phenyl-2-propanone (BMK)\n1 L\n0.25 L\n1-Phenyl-2-propanone oxime\n1 kg\n0.25 kg\nPhosphorus\n0.4 kg\n0.1 kg\nPhosphorous acid\n1 L\n0.25 L\nPiperidine\n0.2 kg\n0.05 kg\nPiperonal\n0.4 kg\n0.1kg\nPlatinum\n0.02 kg\n0.005 kg\nPotassium\n1 kg\n0.25 kg\nPropionic anhydride\n0.2 L\n0.05 L\nPseudoephedrine\n1 kg\n0.25 kg\nPyridine\n4 L\n1 L\n2-Pyrrolidone\n6 L\n1.5 L\nRaney nickel\n0.2 kg\n0.05 kg\nSafrole\n0.4 L\n0.1 L\nSassafras oil\n0.4 L\n0.1 L\nSodium\n1 kg\n0.25 kg\nSodium bis(2-methoxyethoxy) aluminium hydride\n0.2 kg\n0.05 kg\nSodium borohydride\n0.2 kg\n0.05 kg\nSodium cyanoborohydride\n0.2 kg\n0.05 kg\nThionyl chloride\n1 kg\n0.25 kg\nThorium\n4 kg\n1 kg\nSchedule 3—Controlled plants\nPart 1—Controlled plants other than cannabis plants\n\n\nLarge commercial\nCommercial\nTrafficable\nany plant of the genus Erythroxylum P. Browne from which cocaine can be extracted either directly or by chemical transformation, including Erythroxylum coca Lam and Erythroxylum nova-granatense\n800 kg\n80 kg\n800 g\nPapaver bracteatum Lindley\n\t(a)\tif each plant weighs less than 100 g—10 000 plants; or\n\t(a)\tif each plant weighs less than 100 g—1 000 plants; or\n\t(a)\tif each plant weighs less than 10 g—100 plants; or\n\n\t(b)\tin any other case—1 000 kg\n\t(b)\tin any other case—100 kg\n\t(b)\tin any other case—1 kg\nPapaver somniferum L\n\t(a)\tif each plant weighs less than 100 g—10 000 plants; or\n\t(a)\tif each plant weighs less than 100 g—1 000 plants; or\n\t(a)\tif each plant weighs less than 10 g—100 plants; or\n\n\t(b)\tin any other case—1 000 kg\n\t(b)\tin any other case—100 kg\n\t(b)\tin any other case—1 kg\nall fungi that contain PSILOCIN\n10 kg\n2.5 kg\n1 000g\nall fungi that contain PSILOCYBINE (PSILOCYBIN)\n10 kg\n2.5 kg\n1 000g\nany plant containing MESCALINE including any plant of the genus Lophophora\n\n\n\nSalvia divinorum EPL. & Jativa (Diviners Sage)\n\n\n\nMitragyna speciosa Korth (Kratom)\n\n\n\nCatha edulis Forsk (Khat)\n5 kg\n2.5 kg\n250 g\nany species of the genus Ephedra which contains ephedrine\n200 kg\n50 kg\n10 kg\nPart 2—Cannabis plants\n\n\nLarge commercial\nCommercial\nTrafficable\nany plant of the genus Cannabis L\n100 plants\n20 plants\n10 plants\nSchedule 4—Certificate of analysis\n(regulation 18)\nCertificate of analysis\nPursuant to section 53 of the Controlled Substances Act 1984, I ... [print full name and business address], an Analyst appointed under the Controlled Substances Act 1984, certify that ... [insert results of analysis].\nSignature of Analyst:\nDate:\nSchedule 5—Expiation fees\n\n1\nOffence arising out of the possession of cannabis—\n\n\n\t(a)\twhere the amount is less than 25 g\n$250\n\n\t(b)\twhere the amount is 25 g or more but not more than 100 g\n$400\n2\nOffence arising out of the possession of cannabis resin—\n\n\n\t(a)\twhere the amount is less than 5 g\n$250\n\n\t(b)\twhere the amount is 5 g or more but not more than 20 g\n$400\n3\nOffence arising out of the smoking or consumption of cannabis or cannabis resin (not being an offence committed in a public place or other prescribed place)\n$250\n4\nOffence arising out of the possession of equipment (1 or more pieces) for use in connection with the smoking or consumption of cannabis or cannabis resin (not being an offence involving the possession of such equipment for commercial purposes)\n$250\n5\nOffence referred to in item 4 accompanied by another simple cannabis offence relating to the possession, smoking or consumption of cannabis or cannabis resin\n$130\n6\nOffence involving cultivation of 1 cannabis plant\n$400\nSchedule 6—Transitional provisions\n2—Transitional provisions\nA declaration in force under regulation 8A of the Controlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2000 immediately before the commencement of these regulations continues as if it were a declaration under regulation 12 of these regulations.\nLegislative history\nNotes\n\t•\tPlease note—References in the legislation to other legislation or instruments or to titles of bodies or offices are not automatically updated as part of the program for the revision and publication of legislation and therefore may be obsolete.\n\t•\tEarlier versions of these regulations (historical versions) are listed at the end of the legislative history.\n\t•\tFor further information relating to the Act and subordinate legislation made under the Act see the Index of South Australian Statutes or www.legislation.sa.gov.au.\nLegislation revoked by principal regulations\nThe Controlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2014 revoked the following:\nControlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2000\nPrincipal regulations and variations\nNew entries appear in bold.\nYear\nNo\nReference\nCommencement\n2014\n236\nGazette 4.9.2014 p4247\n4.9.2014: r 2\n2015\n187\nGazette 23.7.2015 p3535\n23.7.2015: r 2\n2015\n243\nGazette 3.12.2015 p5161\n3.12.2015: r 2\n2017\n304\nGazette 7.11.2017 p4527\n12.11.2017: r 2\n2018\n191\nGazette 26.7.2018 p2922\n26.7.2018: r 2\n2019\n181\nGazette 27.6.2019 p2569\n1.7.2019: r 2\n2019\n226\nGazette 31.10.2019 p3622\n31.10.2019: r 2\n2021\n143\nGazette 16.9.2021 p3571\n16.9.2021: r 2\n2023\n63\nGazette 29.6.2023 p2074\n1.7.2023: r 2\n2024\n24\nGazette 8.5.2024 p811\n8.5.2024: r 2\n2024\n57\nGazette 27.6.2024 p1917\n27.6.2024: r 2\nProvisions varied\nNew entries appear in bold.\nEntries that relate to provisions that have been deleted appear in italics.\nProvision\nHow varied\nCommencement\nr 2\nomitted under Legislation Revision and Publication Act 2002\n23.7.2015\nr 3\n\n\ncertified hemp seed\ninserted by 304/2017 r 4(1)\n12.11.2017\nindustrial hemp\ninserted by 304/2017 r 4(2)\n12.11.2017\nlow THC cannabis\ninserted by 304/2017 r 4(2)\n12.11.2017\nlow THC cannabis food product\ninserted by 304/2017 r 4(2)\n12.11.2017\nprescribed industrial hemp authority\ninserted by 304/2017 r 4(2)\n12.11.2017\nseed\ninserted by 304/2017 r 4(2)\n12.11.2017\nUniform Poisons Standard\ninserted by 304/2017 r 4(2)\n12.11.2017\nr 5\n\n\nr 5(1)\nvaried by 304/2017 r 5(1), (2)\n12.11.2017\nr 6A\ninserted by 304/2017 r 6\n12.11.2017\nr 8A\ninserted by 304/2017 r 7\n12.11.2017\nr 9\n\n\nr 9(1)\namended by 24/2024 r 3\n8.5.2024\nSch 1\n\n\nPt 1\nsubstituted by 187/2015 r 4(1)\n23.7.2015\n\nvaried by 243/2015 r 4(1)—(4)\n3.12.2015\n\nvaried by 304/2017 r 8(1), (2)\n12.11.2017\n\nvaried by 191/2018 r 4\n26.7.2018\n\nvaried by 226/2019 r 4\n31.10.2019\n\nvaried by 143/2021 r 4(1)—(12)\n16.9.2021\n\namended by 63/2023 r 3(1), (2)\n1.7.2023\n\namended by 57/2024 r 3(1)—(17)\n27.6.2024\nPt 2\nvaried by 187/2015 r 4(2)\n23.7.2015\n\nvaried by 304/2017 r 8(3), (4)\n12.11.2017\n\namended by 63/2023 r 3(3), (4)\n1.7.2023\nSch 2\nvaried by 304/2017 r 9(1), (2)\n12.11.2017\nSch 3\n\n\nPt 1\namended by 63/2023 r 4\n1.7.2023\nSch 5\nvaried by 304/2017 r 10(1), (2)\n12.11.2017\n\nsubstituted by 181/2019 r 4\n1.7.2019\nSch 6\n\n\ncl 1\nomitted under Legislation Revision and Publication Act 2002\n23.7.2015\nHistorical versions\n23.7.2015\n\n3.12.2015\n\n12.11.2017\n\n26.7.2018\n\n1.7.2019\n\n13.10.2019\n\n16.9.2021\n\n1.7.2023\n\n8.5.2024\n\n","sortOrder":0}],"analysis":{"issue_detection":{"absurdities":[],"contradictions":[]},"kimi_summary":{"content_quality":"ok","complexity_score":8,"scope_assessment":{"changed":true,"description":"The regulations have expanded significantly beyond traditional drug control. Originally focused on prohibiting illicit substances, the scope now encompasses: (1) a complex regulatory framework for the legal industrial hemp industry with detailed chemical thresholds and licensing cross-references; (2) harm minimisation protections for health professionals and needle exchange programs; (3) sophisticated electronic drug detection protocols; (4) therapeutic use exemptions for MDMA and psilocybin in clinical settings; and (5) equipment controls targeting hydroponic cultivation and clandestine manufacture. The hemp provisions in particular represent a major expansion from prohibition to regulated legal industry."},"complexity_factors":["Extensive cross-referencing between the regulations, the parent Act (Controlled Substances Act 1984), and the Commonwealth Poisons Standard","Multiple measurement systems used simultaneously—pure weight, mixed weight, and 'discrete dosage units' (DDUs)—creating parallel quantity thresholds","Highly technical chemical nomenclature with over 200 specific substances listed, many with multiple synonyms and structural variants (salts, isomers, analogues, homologues)","Nested exemption structures for industrial hemp products with precise chemical thresholds (e.g., 'not more than 75 mg/kg of cannabidiol' with additional conditions)","Conditional quantity tables that vary by plant weight, maturity, and form (fresh vs dried)","Dual-purpose equipment provisions that apply regardless of whether equipment is working or modified","Frequent amendments (10+ variations since 2014) creating layered legislative history that must be read together","Specific procedural requirements for sampling, analysis, and certification with prescribed fees ($207 per substance)"],"plain_english_summary":"These South Australian regulations work under the Controlled Substances Act 1984 to set the detailed rules for illegal drugs, drug-making chemicals, and prohibited plants. They do three main things: First, they list exactly which substances are banned (including hundreds of specific drugs like heroin, cocaine, synthetic cannabinoids, and psychedelics) and set quantity thresholds that determine how serious an offence is—from simple possession to large-scale trafficking. Second, they create exemptions for industrial hemp and low-THC cannabis food products (like hemp seeds and oil) that meet specific chemical limits, distinguishing legal hemp from illegal cannabis. Third, they regulate drug detection methods, prescription equipment used in drug manufacture, and set fines for minor cannabis offences. The regulations also protect doctors, pharmacists and needle exchange programs from being charged as accessories when they supply syringes or safety advice to drug users."},"flash_summary_failed":{"failed":true,"reason":"A positive credit balance is required for all requests, including BYOK, so fallback providers remain available. Add credits at https://vercel.com/d?to=%2F%5Bteam%5D%2F%7E%2Fai%3Fmodal%3Dtop-up to continue.","source":"analysis-cron"},"flash_summary":{"complexity_score":8,"scope_assessment":{"changed":true,"description":"The regulation's scope has been expanded and refined since the original instrument. Notable changes recorded in the legislative history include insertion of industrial hemp and low‑THC definitions into the interpretation (reg 3, varied by 304/2017 r 4(1), (2) 12.11.2017), creation of specific hemp‑related exemptions (regs 6A and 8A, inserted by 304/2017 r 6–7, 12.11.2017), amendments to prescribed equipment (r 9 amended by 24/2024 r 3, 8.5.2024) and multiple variations to Schedules 1–3 across 2015–2024. Those amendments broadened regulated categories and added carve‑outs and operational detail (definitions, thresholds, exemptions and equipment lists) relative to earlier versions."},"complexity_factors":["Extensive schedules with many substances and three distinct quantity thresholds (Large commercial, Commercial, Trafficable) including separate columns for pure/mixed/DDUs (reg 6; Schedules 1–3).","Multiple cross‑references to the Controlled Substances Act 1984 (definitions such as large commercial, commercial, trafficable) and to external instruments like the Uniform Poisons Standard (reg 3).","Detailed definitional overlay for industrial hemp, low THC cannabis and low THC food products with specific numeric cannabinoid limits (reg 3; regs 6A and 8A).","Prescriptive operational rules for electronic drug detection, sample collection and laboratory analysis (reg 4; regs 16–18; Schedule 4).","Lists of prescribed equipment tied to possession/manufacture offences, with equipment and working‑order rules (regs 9 and 11).","Administrative measures: expiation fee schedule for simple cannabis offences and specified form/fee for analysis (regs 14, 17; Schedule 5).","Ministerial discretion and declaratory powers (health risk minimisation program declarations and variations) affecting immunity from accessorial liability (reg 12).","Frequent amendments and transitional provisions across years, requiring careful tracking of current text versus earlier versions (legislative history)."],"plain_english_summary":"These regulations list which drugs, precursors and plants are \"controlled\", set numeric thresholds for commercial and trafficable quantities, prescribe prohibited equipment and permitted exemptions (including industrial hemp and low‑THC food products), and set rules for electronic drug detection, sampling, analysis and expiation fees for simple cannabis offences. They affect law enforcement, licensed hemp authorities, medical and laboratory personnel, suppliers and the public by calibrating criminal thresholds, permitted possession/supply and administrative fees."},"summary":{"complexity_score":3,"scope_assessment":{"changed":false,"description":"Unable to assess whether the scope changed from original intent — the legislative text was not accessible due to a page-not-found error on the South Australian legislation website. No meaningful scope comparison can be made without the actual content of the regulations."},"complexity_factors":["Actual legislative text was unavailable due to a broken URL — analysis is based on title only","Regulations of this type typically involve complex schedules listing hundreds of substances by chemical name","Interaction between the parent Act (Controlled Substances Act 1984 SA) and these regulations adds interpretive layers","Precursor chemical rules often require technical scientific knowledge to understand","Score is conservatively low because no text was available to assess true complexity"],"plain_english_summary":"This South Australian regulation supplements the Controlled Substances Act 1984 by defining and regulating controlled drugs, drug precursors and controlled plants—setting rules that affect anyone who possesses, uses, manufactures, supplies or handles these substances (including patients, pharmacists, doctors, chemical suppliers and law enforcement). It matters because it governs legal access, diversion risk and criminal enforcement around drugs and precursor chemicals.\n\nThe full text couldn’t be loaded from the legislation website; check legislation.sa.gov.au for the definitive instrument."}},"importantCases":[],"_links":{"self":"/api/acts/controlled-substances-controlled-drugs-precursors-and-plants-regulations-2014","history":"/api/acts/controlled-substances-controlled-drugs-precursors-and-plants-regulations-2014/history","analysis":"/api/acts/controlled-substances-controlled-drugs-precursors-and-plants-regulations-2014/analysis","conflicts":"/api/acts/controlled-substances-controlled-drugs-precursors-and-plants-regulations-2014/conflicts","importantCases":"/api/acts/controlled-substances-controlled-drugs-precursors-and-plants-regulations-2014/important-cases","documents":"/api/acts/controlled-substances-controlled-drugs-precursors-and-plants-regulations-2014/documents"}}